Curis Inc

CRIS Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Insiders
Institutions
Government
Ownership

Chart provided by TradingView

Income
Balance Sheet
Cash Flow
CRIS Income Statement
CRIS Balance Sheet
CRIS Cash Flow
Congress Trading

Recent trades of CRIS by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
CRIS Stock Insider Trading Activity
Name
Type
Shares
Price
Shares Held
Date
Reported
CRIS Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
CRIS Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported
Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by CRIS's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard
Corporate Lobbying

Government lobbying spending instances

  • $15,000 Jan 18, 2018 Issue: Economics/Economic Development
  • $10,000 Jul 16, 2017 Issue: Economics/Economic Development
  • $10,000 Apr 18, 2017 Issue: Economics/Economic Development
  • $10,000 Jan 19, 2017 Issue: Economics/Economic Development
  • $10,000 Oct 16, 2016 Issue: Economics/Economic Development
  • $10,000 Jul 17, 2016 Issue: Economics/Economic Development
  • $10,000 Apr 19, 2016 Issue: Economics/Economic Development
  • $10,000 Jan 17, 2016 Issue: Economics/Economic Development
  • $10,000 Oct 18, 2015 Issue: Economics/Economic Development
  • $10,000 Apr 19, 2015 Issue: Economics/Economic Development
  • $10,000 Jan 19, 2015 Issue: Economics/Economic Development
  • $10,000 Oct 11, 2014 Issue: Indian/Native American Affairs
Corporate Lobbying

Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Conjoint therapies for immunomodulation Aug. 20, 2024
  • Patent Title: Crystal forms of immunomodulators Mar. 26, 2024
  • Patent Title: Phosphoinositide 3-kinase inhibitor with a zinc binding moiety May. 23, 2023
  • Patent Title: Crystal forms of immunomodulators May. 09, 2023
  • Patent Title: Phosphoinositide 3-kinase inhibitors with a zinc binding moiety Mar. 07, 2023
  • Patent Title: Phosphoinositide 3-kinase inhibitors with a zinc binding moiety Mar. 01, 2022
  • Patent Title: Combination therapy with a phosphoinositide 3-kinase inhibitor with a zinc binding moiety Feb. 01, 2022
  • Patent Title: Phosphoinositide 3-kinase inhibitor with a zinc binding moiety Oct. 05, 2021
  • Patent Title: Crystal forms of immunomodulators Jun. 22, 2021
  • Patent Title: Phosphoinositide 3-kinase inhibitors with a zinc binding moiety Jan. 19, 2021
  • Patent Title: Fused amino pyridine as hsp90 inhibitors Nov. 24, 2020
  • Patent Title: Compounds and compositions for treating hematological disorders Sep. 01, 2020
  • Patent Title: Phosphoinositide 3-kinase inhibitors with a zinc binding moiety Jun. 09, 2020
  • Patent Title: Phosphoinositide 3-kinase inhibitor with a zinc binding moiety Jan. 28, 2020
  • Patent Title: Fused amino pyridine as hsp90 inhibitors Oct. 01, 2019
  • Patent Title: Phosphoinositide 3-kinase inhibitors with a zinc binding moiety Jul. 02, 2019
  • Patent Title: Hedgehog antagonists having zinc binding moieties Feb. 26, 2019
  • Patent Title: Phosphoinositide 3-kinase inhibitor with a zinc binding moiety Oct. 30, 2018
  • Patent Title: Fused amino pyridine as hsp90 inhibitors Jul. 31, 2018
  • Patent Title: Phosphoinositide 3-kinase inhibitors with a zinc binding moiety Aug. 08, 2017
  • Patent Title: Phosphoinositide 3-kinase inhibitor with a zinc binding moiety May. 23, 2017
  • Patent Title: Fused amino pyridine as hsp90 inhibitors Apr. 25, 2017
  • Patent Title: Fused amino pyridine as hsp90 inhibitors Aug. 02, 2016
  • Patent Title: Pyridyl inhibitors of hedgehog signalling Apr. 26, 2016
  • Patent Title: Phosphoinositide 3-kinase inhibitor with a zinc binding moiety Feb. 02, 2016
  • Patent Title: Mediators of hedgehog signaling pathways, compositions and uses related thereto Nov. 03, 2015
  • Patent Title: Tyrosine kinase inhibitors containing a zinc binding moiety Oct. 27, 2015
  • Patent Title: Crystalline forms of fused amino pyridines as hsp90 inhibitors Oct. 06, 2015
  • Patent Title: Quinazoline based egfr inhibitors Aug. 18, 2015
  • Patent Title: Fused amino pyridine as hsp90 inhibitors May. 26, 2015
  • Patent Title: Quinazoline based egfr inhibitors containing a zinc binding moiety May. 05, 2015
  • Patent Title: Quinazoline based egfr inhibitors containing a zinc binding moiety Mar. 10, 2015
  • Patent Title: Phosphoinositide 3-kinase inhibitors with a zinc binding moiety Dec. 09, 2014
  • Patent Title: Small organic molecule regulators of cell proliferation Oct. 07, 2014
  • Patent Title: Tartrate salts of quinazoline based egfr inhibitors containing a zinc binding moiety Sep. 30, 2014
  • Patent Title: Mediators of hedgehog signaling pathways, compositions and uses related hereto Aug. 26, 2014
  • Patent Title: Rna interference modulators of hedgehog signaling and uses thereof Aug. 12, 2014
  • Patent Title: Mediators of hedgehog signaling pathways, compositions and uses related thereto Jul. 08, 2014
  • Patent Title: Fused amino pyridines for the treatment of brain tumors May. 13, 2014
  • Patent Title: Phosphoinositide 3-kinase inhibitor with a zinc binding moiety Apr. 29, 2014
  • Patent Title: Cdk inhibitors Apr. 08, 2014
  • Patent Title: Variant hhip1 protein and methods and uses thereof Jan. 07, 2014
  • Patent Title: Quinazoline based egfr inhibitors containing a zinc binding moiety Dec. 10, 2013
  • Patent Title: Fused amino pyridine as hsp90 inhibitors Nov. 19, 2013
  • Patent Title: Cdk inhibitors containing a zinc binding moiety Oct. 22, 2013
  • Patent Title: Formulation of quinazoline based egfr inhibitors containing a zinc binding moiety Aug. 27, 2013
  • Patent Title: Methods of inhibiting unwanted cell proliferation using an antibody that binds to sonic hedgehog and inhibits hedgehog signaling Jul. 16, 2013
  • Patent Title: Phosphoinositide 3-kinase inhibitors with a zinc binding moiety Jun. 11, 2013
  • Patent Title: Quinazoline based egfr inhibitors containing a zinc binding moiety Jun. 04, 2013
  • Patent Title: Tyrosine kinase inhibitors containing a zinc binding moiety Apr. 23, 2013
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
WallStreetBets

Number of mentions of CRIS in WallStreetBets Daily Discussion

CRIS News

Recent insights relating to CRIS

CNBC Recommendations

Recent picks made for CRIS stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in CRIS

CRIS Top Shareholders
Shareholder
Shares Held
CRIS Options Owners
Shareholder
Security
Underlying Shares

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

CRIS Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view CRIS Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
Back To Top